Stephen Eck
Chief Tech/Sci/R&D Officer at MACROGENICS, INC.
Net worth: 144 227 $ as of 31/03/2024
Profile
Stephen L.
Eck currently works at Personalized Medicine Coalition, as Director, CirculoGene Theranostics, Inc., as Director, Central Pennsylvania Clinic, as Director, MacroGenics, Inc., as Chief Medical Officer & SVP-Clinical Development from 2020, and Keck Graduate Institute of Applied Life Sciences, as Trustee.
Dr. Eck also formerly worked at Aravive Biologics, Inc., as President & Chief Executive Officer from 2017 to 2018, Luminex Corp., as Independent Director from 2016 to 2021, Eli Lilly & Co., as Vice President-Translation Medicine from 2007 to 2011, Pfizer Inc., as Head-Clinical Oncology, the University of Pennsylvania, as Assistant Professor, Astellas Pharma Global Development, Inc., as Vice President-Oncology Medical Sciences from 2011 to 2017, and Immatics US, Inc., as Chief Medical Officer.
Dr. Eck received his doctorate degree from Harvard University, undergraduate degree from Kalamazoo College, and doctorate degree from the University of Mississippi Medical Center.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
MACROGENICS, INC.
0.02% | 22/03/2024 | 9,798 ( 0.02% ) | 144 227 $ | 31/03/2024 |
Stephen Eck active positions
| Companies | Position | Start |
|---|---|---|
| MACROGENICS, INC. | Chief Tech/Sci/R&D Officer | 01/07/2020 |
| Keck Graduate Institute of Applied Life Sciences | Director/Board Member | - |
| Central Pennsylvania Clinic | Director/Board Member | - |
Personalized Medicine Coalition
 Personalized Medicine Coalition Miscellaneous Commercial ServicesCommercial Services The Personalized Medicine Coalition promotes the understanding and adoption of personalized medicine concepts, services, and products. The private company is based in Washington and was founded by Patrick F. Terry. | Director/Board Member | - |
CirculoGene Theranostics, Inc.
 CirculoGene Theranostics, Inc. Medical SpecialtiesHealth Technology CirculoGene Theranostics LLC operates as a molecular diagnostics company. It develops test for deoxyribonucleic acid liquid biopsies. It offers next-generation sequencing (NGS) method to provide full genomic load analysis, enabling accurate data to help clinicians and their patients. The company was founded by Chen-Hsiung Yeh in 2015 and is headquartered in Birmingham, AL. | Director/Board Member | - |
Former positions of Stephen Eck
| Companies | Position | End |
|---|---|---|
| LUMINEX CORPORATION | Director/Board Member | 14/07/2021 |
Aravive Biologics, Inc.
 Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX. | Chief Executive Officer | 01/03/2018 |
Astellas Pharma Global Development, Inc.
 Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL. | Corporate Officer/Principal | 01/01/2017 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/01/2011 |
| ░░░░░░░░░░ ░░ ░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Stephen Eck
| Harvard University | Doctorate Degree |
| Kalamazoo College | Undergraduate Degree |
| University of Mississippi Medical Center | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| PFIZER, INC. | Health Technology |
| MACROGENICS, INC. | Health Technology |
| Private companies | 7 |
|---|---|
Luminex Corp.
 Luminex Corp. Medical SpecialtiesHealth Technology Luminex Corp. develops, manufactures and markets proprietary biological testing technologies and products with applications throughout the life sciences and diagnostics industries. The firm's products are focused on the molecular diagnostic testing market, which includes human genetics, personalized medicine and infectious disease segments. The company was founded by Mark B. Chandler and Van S. Chandler in May 1995 and is headquartered in Austin, TX. | Health Technology |
Personalized Medicine Coalition
Personalized Medicine Coalition Miscellaneous Commercial ServicesCommercial Services The Personalized Medicine Coalition promotes the understanding and adoption of personalized medicine concepts, services, and products. The private company is based in Washington and was founded by Patrick F. Terry. | Commercial Services |
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL. | Health Technology |
Aravive Biologics, Inc.
Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX. | Health Technology |
CirculoGene Theranostics, Inc.
CirculoGene Theranostics, Inc. Medical SpecialtiesHealth Technology CirculoGene Theranostics LLC operates as a molecular diagnostics company. It develops test for deoxyribonucleic acid liquid biopsies. It offers next-generation sequencing (NGS) method to provide full genomic load analysis, enabling accurate data to help clinicians and their patients. The company was founded by Chen-Hsiung Yeh in 2015 and is headquartered in Birmingham, AL. | Health Technology |
Immatics US, Inc.
 Immatics US, Inc. BiotechnologyHealth Technology Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX. | Health Technology |
| Central Pennsylvania Clinic |
- Stock Market
- Insiders
- Stephen Eck
